Pulmonary vascular disease

Pulmonary vascular disease

Socioeconomic status and survival in patients with pulmonary hypertension
Mei-Sing Ong

ERJ Open Research Oct 2020, 6 (4) 00638-2020; DOI: 10.1183/23120541.00638-2020
COVID-19 in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: a reference centre survey
Catharina Belge, Rozenn Quarck, Laurent Godinas, David Montani, Pilar Escribano Subias, Jean-Luc Vachiéry, Heba Nashat, Joanna Pepke-Zaba, Marc Humbert, Marion Delcroix

ERJ Open Research Oct 2020, 6 (4) 00520-2020; DOI: 10.1183/23120541.00520-2020
Mid-regional pro-atrial natriuretic peptide and copeptin as indicators of disease severity and therapy response in CTEPH
Steffen D. Kriechbaum, Lillith Scherwitz, Christoph B. Wiedenroth, Felix Rudolph, Jan-Sebastian Wolter, Moritz Haas, Ulrich Fischer-Rasokat, Andreas Rolf, Christian W. Hamm, Eckhard Mayer, Stefan Guth, Till Keller, Stavros V. Konstantinides, Mareike Lankeit, Christoph Liebetrau

ERJ Open Research Oct 2020, 6 (4) 00356-2020; DOI: 10.1183/23120541.00356-2020
ERS International Congress, Madrid, 2019: highlights from the Pulmonary Vascular Diseases Assembly
Sheila Ramjug, Jason Weatherald, Sandeep Sahay, Johad Khoury, Vasile Foris, Nagaraj Chandran, Aleksandar Bokan, Laurent Godinas, Marion Delcroix

ERJ Open Research Oct 2020, 6 (4) 00304-2020; DOI: 10.1183/23120541.00304-2020
Pulmonary arterial hypertension-associated changes in gut pathology and microbiota
Ravindra K. Sharma, Aline C. Oliveira, Tao Yang, Seungbum Kim, Jasenka Zubcevic, Victor Aquino, Gilberto O. Lobaton, Ruby Goel, Elaine M. Richards, Mohan K. Raizada

ERJ Open Research Jul 2020, 6 (3) 00253-2019; DOI: 10.1183/23120541.00253-2019
Pulmonary arterial hypertension in breast cancer patients on HER2-targeted therapy: a review of FDA Adverse Events Reporting System data
Godsfavour Umoru, Matthew Taitano, Sarah Beshay, Polly Niravath, Sandeep Sahay

ERJ Open Research Apr 2020, 6 (2) 00199-2020; DOI: 10.1183/23120541.00199-2020
Sex-specific and age-related seasonal variations regarding incidence and in-hospital mortality of pulmonary embolism in Germany
Karsten Keller, Lukas Hobohm, Thomas Münzel, Stavros V. Konstantinides, Mareike Lankeit

ERJ Open Research Apr 2020, 6 (2) 00181-2020; DOI: 10.1183/23120541.00181-2020
Chronic thromboembolic pulmonary hypertension in Saudi Arabia: preliminary results from the SAUDIPH registry
Abdullah M. Aldalaan, Sarfraz A. Saleemi, Ihab Weheba, Abeer Abdelsayed, Pekka Hämmäinen, Maha M. Aleid, Fatima Alzubi, Hamdeia Zaytoun, Nadeen Alharbi

ERJ Open Research Apr 2020, 6 (2) 00218-2019; DOI: 10.1183/23120541.00218-2019
Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity
Anastasia Anthi, Eleni Stagaki, Loukianos Rallidis, Dimitrios Konstantonis, Maria-Eleftheria Evangelopoulos, Konstantinos Voumvourakis, Apostolos Armaganidis, Stylianos E. Orfanos

ERJ Open Research Jan 2020, 6 (1) 00328-2019; DOI: 10.1183/23120541.00328-2019
Performance of pulmonary artery dimensions measured on high-resolution computed tomography scan for identifying pulmonary hypertension
Pailin Ratanawatkul, Andrea Oh, J. Caleb Richards, Jeffrey J. Swigris

ERJ Open Research Jan 2020, 6 (1) 00232-2019; DOI: 10.1183/23120541.00232-2019

Main menu

User menu

Search

Pulmonary vascular disease

Pages

Contact us